retatrutide clinical trials news That Redefined Medicine in 2025 Preventing obesity-related cancer with the

Stopping medication without a plan often leads to weight regain

The approval of GLP-1 RAs, starting with exenatide in 2005, followed by semaglutide and oral formulations, has expanded treatment options for patients seeking effective, long-term solutions for T2DM and obesity (15)

1994 Oct;2(4):259-69

Trump has finally delivered his healthcare proposals, but it seems the 'concept of a plan' promised for many years remains pretty much just that

While this preparation is primarily designed to target pigmentation issues, melasma, and potentially for the treatment of certain types of acne scars owing to its skin-lightening and anti-inflammatory properties, it may also offer other dermatological benefits

[DOI] [PubMed] [Google Scholar] 315